McCarter Private Wealth Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$622K Buy
10,261
+2,075
+25% +$121K 0.27% 81
2025
Q4
$442K Buy
8,186
+3,255
+66% +$157K 0.2% 99
2025
Q3
$222K Buy
4,931
+235
+5% +$11K 0.11% 120
2025
Q2
$217K Hold
4,696
0.12% 109
2025
Q1
$286K Buy
4,696
+150
+3% +$8.74K 0.19% 83
2024
Q4
$257K Sell
4,546
-552
-11% -$30.8K 0.16% 89
2024
Q3
$264K Buy
+5,098
New +$239K 0.17% 87

Other funds holding BMY

McCarter Private Wealth Services's BMY Position: Q1 2026 in Review

McCarter Private Wealth Services increased its Bristol-Myers Squibb (BMY) stake by 25% in Q1 2026, buying an estimated $121K and bringing the position to 10,261 shares worth $622K. The position accounts for 0.27% of the portfolio, ranked #81.

McCarter Private Wealth Services first reported a position in BMY in Q3 2024 and has held it in 7 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • McCarter Private Wealth Services held 10,261 shares of Bristol-Myers Squibb worth $622K as of Q1 2026.
  • McCarter Private Wealth Services bought 2,075 Bristol-Myers Squibb shares in Q1 2026, an estimated $121K.
  • Bristol-Myers Squibb made up 0.27% of McCarter Private Wealth Services's portfolio in Q1 2026, its #81 holding.
  • McCarter Private Wealth Services first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 7 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on McCarter Private Wealth Services's 13F filing for Q1 2026, filed 15 May 2026.